Furthermore, decreased expression of PM20D1 has been observed in cardiovascular diseases such as atherosclerosis and gestational diabetes, and lower PM20D1 levels are associated with increased secretion of inflammatory factors, impaired lipid metabolism, and worse prognosis in patients [11, 12]. This evidence concerns the gene PM20D1 and gestational diabetes.